PCVX - Latest News
Vaxcyte, Inc. (PCVX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $8.39B. Beta to the broader market is 1.21.
The article list below shows the most recent PCVX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent PCVX Headlines
If You Followed Seth Klarman Into Vaxcyte in May, He Was Already Long Gone
247wallst.com - Aug 16, 2026
Seth Klarman's Baupost Group eliminated its entire stake in Vaxcyte (NASDAQ:PCVX | PCVX Price Prediction) during the June quarter, according to the 13
Assenagon Asset Management S.A. Decreases Stock Holdings in Vaxcyte, Inc. $PCVX
defenseworld.net - Aug 12, 2026
Assenagon Asset Management S. A.
Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com - Aug 5, 2026
Topline Safety, Tolerability and Immunogenicity Data from VAX-31 Adult Phase 3 OPUS-1 Trial Expected in Fourth Quarter of 2026; OPUS-2 and OPUS-3 Phas
Vaxcyte, Inc. (NASDAQ:PCVX) Receives Consensus Recommendation of “Hold” from Analysts
defenseworld.net - Aug 4, 2026
Shares of Vaxcyte, Inc. (NASDAQ: PCVX - Get Free Report) have been given an average rating of "Hold" by the nine analysts that are covering the compa
Bank of New York Mellon Corp Has $27.57 Million Stock Holdings in Vaxcyte, Inc. $PCVX
defenseworld.net - Jul 28, 2026
Bank of New York Mellon Corp lifted its holdings in shares of Vaxcyte, Inc. (NASDAQ: PCVX) by 5.
How News Affects PCVX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track PCVX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked PCVX news questions
- What is the latest PCVX news headline?
- The most recent PCVX headline (Aug 16, 2026) is "If You Followed Seth Klarman Into Vaxcyte in May, He Was Already Long Gone". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the PCVX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What PCVX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual PCVX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.